Altimmune ALT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$22.56M-15.3% | -$27.36M-18.0% | -$19.01M+16.8% | -$22.15M+10.1% | -$19.58M+19.8% | ||
| $23K-20.7% | $26K-21.2% | $27K-27.0% | $30K-50.8% | $29K-72.9% | ||
| $3.38M-15.9% | $4.94M+47.3% | $3.55M+15.5% | $3.57M-17.3% | $4.02M+10.0% | ||
| -$20.94M-24.4% | -$19.45M-6.5% | -$11.9M+56.1% | -$19.35M-6.9% | -$16.84M-3.0% | ||
| $21K— | $1K— | —— | —— | —— | ||
| -$3.69M+27.7% | -$79.16M— | -$149.32M— | $101.11M+2,836% | -$5.1M+87.1% | ||
| $78.47M+130% | $81.13M+704% | $39.35M+14,693% | $52.24M+113,674% | $34.12M+13,172% | ||
| $53.84M+342% | —— | —— | $134M+713% | $12.18M+122% | ||
| -$20.96M— | -$19.45M— | -$11.9M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Altimmune generate?
- Altimmune (ALT) generated -$71.6M in operating cash flow over the trailing twelve months.
- What is Altimmune's free cash flow?
- After $111.0K of capital expenditures, Altimmune's free cash flow was -$68.8M over the trailing twelve months, up 10.2% year over year.
- Where does Altimmune's cash flow data come from?
- Every line is extracted from Altimmune's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.